Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 4/20 | 0.52 |
| ▸ | ADH1A | P07327 | 4/20 | 0.52 |
| ▸ | ADH1C | P00326 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 3/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123088 | 0.86 | — | — | |
| SCHEMBL3859640 | 0.86 | — | — | |
| SCHEMBL5878360 | 0.85 | KDM4E (0.61) | ADH1BADH1AADH1CKDM4EADH7 | |
| SCHEMBL1002824 | 0.84 | — | — | |
| SCHEMBL8070055 | 0.84 | — | — | |
| SCHEMBL5878376 | 0.84 | — | — | |
| SCHEMBL13875203 | 0.82 | ADH1B (0.43) | ADH1BADH1AADH1CKDM4EADH7 | |
| SCHEMBL3670984 | 0.81 | — | — | |
| SCHEMBL15904135 | 0.80 | SLC22A6 (0.52) | ADH1BADH1AADH1CKDM4E | |
| SCHEMBL16350144 | 0.78 | ADH1B (0.39) | ADH1BADH1AADH1CKDM4EADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253517-A1 | METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253517-A1 | METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF | SLC6A15, SLC6A19, ALAD | ADH1B 583/4885ADH1A 1881/4885ADH1C 2020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.